Role of RNTCP in the management of MDR-TB

Background: MDR-TB is defined as resistance to isoniazid and rifampicin to other drugs. India is one of the countries with largest burden of MDR TB in the world. Second line Anti-tuberculous therapy is now available for patients with MDR But there are many challenges for MDR RNTCP data for MDR-TB maintained at a TU, in the city of Ahmedabad, Gujarat, and to compare it with the data available in literature. This study also aimed MDR-TB and to address the same. Material and methods: We had respective Direct Microscopy Center (DMC) with suspicion of MDR 2014 to December 2014. Results: Of the 353 suspected MDR diagnosed to have MDR-TB. Of these 48 patients, 46 patients had pulmonary TB (95.833%) and 2 patients had extra-pulmonary MDR transferred to their respective TU and 40 patients (83.33%) were enrolled for Cat IV from our TU. Of the 40 patients enrolled at our TU, 30 patients (75%) were continuing Cat (25 were on intensive phase and treatment, 01 patient (2.5%) defaulted treatment, 05 patients (12.5%) refused treatment and 01 patient had XDR-TB (2.5%). Of the 40 patients, 05 patients (12.5%) had ofloxacin resistance. No pa had intolerance to any oral or injectable ATT. None of the diagnosed MDR infection. H. Role of RNTCP in the management of MDR-TB. IAIM, 2015; 2(7 , Dipti J Patel, Hiren Parmar